PT  - JOURNAL ARTICLE
AU  - Leclair, Valérie
AU  - Landon-Cardinal, Océane
AU  - Aggarwal, Rohit
AU  - Bansback, Nick
AU  - Campbell, Craig
AU  - Feldman, Brian M. 
AU  - Jarry, Martin
AU  - McNamara, Suzan
AU  - White, Barbara
AU  - Hudson, Marie
TI  - Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis
AID  - 10.3899/jrheum.200480
DP  - 2020 Jun 15
TA  - The Journal of Rheumatology
PG  - jrheum.200480
4099  - http://www.jrheum.org/content/early/2020/06/09/jrheum.200480.short
4100  - http://www.jrheum.org/content/early/2020/06/09/jrheum.200480.full
AB  - The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.